ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

Lutein, found in leafy greens, may counter cognitive aging

Vitamin D3 Versus D2

 
Print Page
Email Article

Celebrex® Study Shows Once-daily Dose As Effective As Twice-daily Dose for Treating Osteoarthritis

  [ Not Yet Rated ]   [ Discuss This Article ]
By News Release • www.ProHealth.com • April 6, 2000


SUMMARY: The results show that in all efficacy measures, both a once a day dose and a twice a day dose of Celebrex are equally beneficial for Ostearthritis (OA) patients. Researchers confirmed that the 200 mg once-daily regimen is effective and safe in treating OA. This offers added convenience and ease for patients who would prefer a once-daily dose

CHICAGO, April 6 /PRNewswire/ -- A recently published study of almost 700 osteoarthritis (OA) patients has found that a single daily dose (QD) of 200 mg of Celebrex ® (celecoxib capsules) is just as effective and safe as two daily doses (BID) of 100 mg each for the treatment of the pain and inflammation of OA.

The primary objective of this prospective, randomized, placebo-controlled, double-blind, outpatient study was to compare the efficacy of a once-daily regimen of Celebrex (200 mg QD) to the 100 mg BID regimen in treating the signs and symptoms of OA. Six hundred and eighty-six patients with OA of the knee in a flare state were enrolled in this parallel-group, multicenter study. Patients were randomly assigned to receive Celebrex 100 mg BID, Celebrex 200 mg QD, or placebo for a six-week treatment period. The results show that in all efficacy measures, both doses of Celebrex produced clinical improvement in the signs and symptoms of OA that were superior to those seen with placebo and essentially indistinguishable from each other.

Commenting on the study's significance, Gary W. Williams, M.D., lead author and head of the Division of Rheumatology at the Scripps Clinic, in La Jolla, California said, "We have confirmed that the 200 mg once-daily regimen is effective and safe in treating OA. This offers added convenience and ease for patients who would prefer a once-daily dose."

Physicians' current prescribing behavior is consistent with these findings; 83 percent of physicians prescribing Celebrex are choosing the once-daily regimen.(1)

Celebrex is the first COX-2 specific inhibitor approved by the U.S. Food and Drug Administration for the treatment of osteoarthritis and adult rheumatoid arthritis, and is co-promoted by Searle and Pfizer Inc. Patients who have a known allergic reaction to celecoxib, certain sulfa drugs called sulfonamides, aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) should not use Celebrex. As with all NSAIDs, serious gastrointestinal toxicity can occur with or without warning symptoms. In clinical trials, the most common side effects of Celebrex were dyspepsia, diarrhea and abdominal pain, which were generally mild to moderate.
Searle, the leading arthritis company worldwide, is the largest provider of branded prescription arthritis medicines in the United States and is the first company to bring COX-2 technology to the marketplace.

Source: Pharmacia Corporation



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
The Surprising Benefits of Probiotics - What You Didn't Know The Surprising Benefits of Probiotics - What You Didn't Know
The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
Relief for Dry, Itchy Skin Caused by Fibromyalgia Relief for Dry, Itchy Skin Caused by Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map